Renin-Angiotensin System Inhibitor is Associated with Lower Risk of Ensuing Chronic Kidney Disease after Functional Recovery from Acute Kidney Injury

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Chou, Yu Hsiang ^a,b   Huang, Tao Min ^a   Pan, Szu Yu ^a,b,c   Chang, Chin Hao ^a   Lai, Chun Fu ^a   Wu, Vin Cent ^a   Wu, Ming Shiou ^a   Wu, Kwan Dun ^a   Chu, Tzong Shinn ^a   Lin, Shuei Liong ^a,b,d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE KIDNEY FAILURE; ADULT; AGED; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPLICATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SURVIVAL RATE;

ACUTE KIDNEY INJURY; ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RENIN-ANGIOTENSIN SYSTEM; SURVIVAL RATE;

EID: 85017437734     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep46518     Document Type: Article

References (63)

1. Lafrance, J. P., Miller, D. R. Acute kidney injury associates with increased long-term mortality. J Am Soc Nephrol 21, 345-352(2010).
2. Yang, L., et al. Acute kidney injury in China: A cross-sectional survey. Lancet 386, 1465-1471 (2015).
3. Xu, X., et al. Epidemiology and clinical correlates of AKI in Chinese hospitalized adults. Clin J Am Soc Nephrol 10, 1510-1518 (2015).
4. Mehta, R. L., et al. Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 GlobalSnapshot: A multinational cross-sectional study. Lancet 387, 2017-2025 (2016).
5. Chawla, L. S., Kimmel, P. L. Acute kidney injury and chronic kidney disease: An integrated clinical syndrome. Kidney Int 82, 516-524 (2012).
6. Lai, C. F., et al. Kidney function decline after a non-dialysis-requiring acute kidney injury is associated with higher long-termmortality in critically ill survivors. Crit Care 16, R123 (2012).
7. Chawla, L. S., Eggers, P. W., Star, R. A., Kimmel, P. L. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371, 58-66 (2014).
8. Singer, E., et al. Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predictsoutcomes. Kidney Int 80, 405-414 (2011).
9. Thakar, C. V., Christianson, A., Himmelfarb, J., Leonard, A. C. Acute kidney injury episodes and chronic kidney disease risk indiabetes mellitus. Clin J Am Soc Nephol 6, 2567-2572 (2011).
10. Heung, M., et al. Acute kidney injury recovery pattern and subsequent risk of CKD: An analysis of Veterans Health AdministrationData. Am J Kidney Dis 67, 742-752 (2016).
11. Chou, Y. H., Pan, S. Y., Yang, C. H., Lin, S. L. Stem cells and kidney regeneration. J Formos Med Assoc 113, 201-209 (2014).
12. Chou, Y. H., et al. The role of brain natriuretic peptide in predicting renal outcome and fluid management in critically ill patients. JFormos Med Assoc 114, 1187-1196 (2015).
13. Chou, Y. H., et al. Impact of timing of renal replacement therapy initiation on outcome of septic acute kidney injury. Crit Care 15, R134 (2011).
14. Ferenbach, D. A., Bonventre, J. V. Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. NatRev Nephrol 11, 264-276 (2015).
15. Yang, L., Besschetnova, T. Y., Brooks, C. R., Shah, J. V., Bonventre, J. V. Epithelial cell cycle arrest in G2/M mediates kidney fibrosisafter injury. Nat Med 16, 535-543 (2010).
16. Chen, Y. T., et al. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive andpost-ischemic kidney fibrosis. Kidney Int 80, 1170-1181 (2011).
17. Wu, C. F., et al. Transforming growth factor beta-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblasttransition in obstructive kidney fibrosis. Am J Pathol 182, 118-131 (2013).
18. Horbelt, M., et al. Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury. Am J Physiiol RenalPhysiol 293, F688-695 (2007).
19. Lin, S. L., et al. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascularrarefaction and fibrosis. Am J Pathol 178, 911-923 (2011).
20. Cheng, S. Y., et al. Losartan reduces ensuing chronic kidney disease and mortality after acute kidney injury. Sci Rep 6, 34265 (2016).
21. Rodriguez-Romo, R., et al. AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidneydisease. Kidney Int 89, 363-373 (2016).
22. Zhang, J., et al. Competing actions of type 1 angiotensin II receptors expressed on T lymphocytes and kidney epithelium duringcisplatin-induced AKI. J Am Soc Nephrol 27, 2257-2264 (2016).
23. Zuk, A., Bonventre, J. V. Acute kidney injury. Annu Rev Med 67, 293-307 (2016).
24. Rewa, O., Bagshaw, S. M. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol 10, 193-207 (2014).
25. Finkenstaedt, J. T., Merrill, J. P. Renal function after recovery from acute renal failure. N Engl J Med 254, 1023-1026 (1956).
26. Newsome, B. B., Warnock, D. G., McClellan, W. M., et al. Long-term risk of mortality and end-stage renal disease among the elderlyafter small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med 168, 609-616(2008).
27. Ishani, A., et al. The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med 171, 226-233 (2011).
28. Wu, V. C., et al. Long-term risk of coronary events after AKI. J Am Soc Nephrol 25, 595-605 (2014).
29. Macedo, E., Zanetta, D. M., Abdulkader, R. C. Long-term follow-up of patients after acute kidney injury: Patterns of renalfunctional recovery. PloS one 7, e36388 (2012).
30. Macedo, E., Bouchard, J., Mehta, R. L. Renal recovery following acute kidney injury. Curr Opin Crit Care 14, 660-665 (2008).
31. Bellomo, R. Defining, quantifying, and classifying acute renal failure. Crit Care Clin 21, 223-237 (2005).
32. Huang, T. M., et al. Preoperative proteinuria predicts adverse renal outcomes after coronary artery bypass grafting. J Am Soc Nephrol22, 156-163 (2011).
33. Shiao, C. C., et al. Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after majorabdominal surgery. Crit Care 13, R171 (2009).
34. Shiao, C. C., et al. U-curve association between timing of renal replacement therapy initiation and in-hospital mortality inpostoperative acute kidney injury. PloS one 7, e42952 (2012).
35. Wu, V. C., et al. The impact of acute kidney injury on the long-term risk of stroke. J Am Heart Assoc 3, e000933 (2014).
36. Wu, V. C., et al. Acute-on-chronic kidney injury at hospital discharge is associated with long-term dialysis and mortality. Kidney Int80, 1222-1230 (2011).
37. Uchino, S., et al. Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 294, 813-818 (2005).
38. Thiele, R. H., Isbell, J. M., Rosner, M. H. AKI associated with cardiac surgery. Clin J Am Soc Nephrol 10, 500-514 (2015).
39. Rosner, M. H., Portilla, D., Okusa, M. D. Cardiac surgery as a cause of acute kidney injury: Pathogenesis and potential therapies. JIntensive Care Med 23, 3-18 (2008).
40. Chertow, G. M., Burdick, E., Honour, M., Bonventre, J. V., Bates, D. W. Acute kidney injury, mortality, length of stay, and costs inhospitalized patients. J Am Soc Nephrol 16, 3365-3370 (2005).
41. Endo, T., et al. Exploring the origin and limitations of kidney regeneration. J Pathol 236, 251-263 (2015).
42. Ko, G. J., et al. Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkersof AKI-to-CKD transition. Am J Physiol Renal Physiol 298, F1472-1483 (2010).
43. Bechtel, W., et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 16, 544-550 (2010).
44. Chang, Y. T., et al. DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys. J Clin Invest 126, 721-731 (2016).
45. Bellomo, R., et al. The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs 31, 166-178(2008).
46. Cao, W., et al. Overexpression of intrarenal renin-angiotensin system in human acute tubular necrosis. Kidney Blood Press Res 41, 746-756 (2016).
47. Rosen, S., Stillman, I. E. Acute tubular necrosis is a syndrome of physiologic and pathologic dissociation. J Am Soc Nephrol 19, 871-875 (2008).
48. Yang, X., et al. Urinary angiotensinogen level predicts AKI in acute decompensated heart failure: A prospective, two-stage study. J AmSoc Nephrol 26, 2032-2041 (2015).
49. Venkatachalam, M. A., et al. Acute kidney injury: A springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol298, F1078-1094 (2010).
50. Hsu, C. Y., et al. Elevated BP after AKI. J Am Soc Nephrol 27, 914-923 (2016).
51. Molnar, M. Z., et al. Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients withchronic kidney disease. J Am Coll Cardiol 63, 650-658 (2014).
52. Lewis, E. J., et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2diabetes. N Engl J Med 345, 851-860 (2001).
53. Brenner, B. M., et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. NEngl J Med 345, 861-869 (2001).
54. Huang, T. M., et al. Association of pre-operative ACEIs or ARBs with a reduction in post-operative AKI after elective CABG. J AmSoc Nephrol 27, 75A (2010).
55. Ronco, C., Haapio, M., House, A. A., Anavekar, N., Bellomo, R. Cardiorenal syndrome. J Am Coll Cardiol 52, 1527-1539 (2008).
56. Yancy, C. W., et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of CardiologyFoundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62, e147-239 (2013).
57. Lund, L. H., Benson, L., Dahlstrom, U., Edner, M. Association between use of renin-angiotensin system antagonists and mortalityin patients with heart failure and preserved ejection fraction. JAMA 308, 2108-2117 (2012).
58. McClellan, W. M., Flanders, W. D. Risk factors for progressive chronic kidney disease. J Am Soc Nephrol 14, S65-70 (2003).
59. Li, L., et al. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and metaanalysisbased on observational cohort studies. BMC Nephrol 15, 122 (2014).
60. Walsh, M., et al. The association between perioperative hemoglobin and acute kidney injury in patients having noncardiac surgery. Anesth Analg 117, 924-931 (2013).
61. Sawhney, S., Mitchell, M., Marks, A., Fluck, N., Black, C. Long-term prognosis after acute kidney injury (AKI): What is the role ofbaseline kidney function and recovery? A systematic review. BMJ Open 5, e006497 (2015).
62. Chen, L. I., et al. Modification of diet in renal disease (MDRD) study and CKD epidemiology collaboration (CKD-EPI) equations forTaiwanese adults. PloS one 9, e99645 (2014).
63. Okusa, M. D., Davenport, A. Reading between the (guide)lines-the KDIGO practice guideline on acute kidney injury in theindividual patient. Kidney Int 85, 39-48 (2014).